Home / Inspections / 1297464

FDA Inspection 1297464 — LGC Clinical Diagnostics, Inc.

LGC Clinical Diagnostics, Inc. — FEI 1220394

The FDA completed an inspection of LGC Clinical Diagnostics, Inc. on December 10, 2025 in Milford, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
December 10, 2025
Fiscal Year
2026
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Milford, MA (United States)

Facility

Other inspections at this facility

  • 775644 (NAI Wed Mar 28 2012 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 733038 (VAI Tue Jun 28 2011 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 614321 (NAI Fri Sep 25 2009 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources